Design of tetrapeptide ligands as inhibitors of the Src SH2 domain

By Nam N.-H.   Pitts R.L.   Sun G.   Sardari S.   Tiemo A.   Xie M.   Yan B.   Parang K.  

Bioorganic and Medicinal Chemistry, Vol. 12, Iss. 4, 2004-02 ,pp. : 779-787

Elsevier

Access to resources Recommend Favorite

Implications of SH3 domain structure and dynamics for protein regulation and drug design

By Gmeiner William   Horita David  

Cell Biochemistry and Biophysics, Vol. 35, Iss. 2, 2001-06 ,pp. : 127-140

Humana Press, Inc

Access to resources Recommend Favorite

Hierarchy of Structure Loss in MD Simulations of src SH3 Domain Unfolding

By Tsai J.   Levitt M.   Baker D.  

Journal of Molecular Biology, Vol. 291, Iss. 1, 1999-08 ,pp. : 215-225

Academic Press

Access to resources Recommend Favorite

Structure-Activity Studies of Phosphopeptidomimetic Prodrugs Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 3 (Stat3)

By Mandal Pijus  

International Journal of Peptide Research and Therapeutics, Vol. 19, Iss. 1, 2013-03 ,pp. : 3-12

Springer Publishing Company

Access to resources Recommend Favorite

Mutational Investigation of the Specificity Determining Region of the Src SH2 Domain

By Bradshaw J.M.   Mitaxov V.   Waksman G.  

Journal of Molecular Biology, Vol. 299, Iss. 2, 2000-06 ,pp. : 523-537

Academic Press

Access to resources Recommend Favorite